Results 41 to 50 of about 4,160,890 (294)

Survival Outcomes and Complications Among Canadian Children With Retinoblastoma: A Population‐Based Report From CYP‐C

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Purpose Retinoblastoma (RB) is the most common pediatric ocular cancer, yet population‐based data on survival and risk factors remain limited. This study aimed to describe survival in a large national RB cohort and identify predictors of death and complications.
Samuel Sassine   +14 more
wiley   +1 more source

Health and Wellness: Black Facts [PDF]

open access: yes, 2015
Every year approximately 85,000 African American deaths are attributed to the Black – White mortality gap. Racial disparities in health in the United States are substantial. Today, death rates for African Americans remain 40% higher than for whites. They

core  

Cladoceran birth and death rates estimates [PDF]

open access: yes, 1987
I. Birth and death rates of natural cladoceran populations cannot be measured directly. Estimates of these population parameters must be calculated using methods that make assumptions about the form of population growth.
Argentesi F.   +34 more
core   +1 more source

Adherence to Protocol Recommendations for Children With Wilms Tumour in Two Consecutive Studies in the United Kingdom and Ireland—Does Variation Matter?

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background and Aims Wilms tumour (WT) has excellent event‐free and overall survival (OS). However, small differences exist between countries participating in the same international study. This led us to examine variation in adherence to protocol recommendations as a potential contributing factor.
Suzanne Tugnait   +23 more
wiley   +1 more source

Sirolimus for Extracranial Arteriovenous Malformations: A Scoping Review of the Evidence in Syndromic and Non‐Syndromic Cases

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Arteriovenous malformations (AVMs) are rare, high‐flow, vascular anomalies that can occur either sporadically or as part of a genetic syndrome. AVMs can progress with serious morbidity and even mortality if left unchecked. Sirolimus is an mTOR inhibitor that is effective in low‐flow vascular malformations; however, its role in AVMs is unclear.
Will Swansson   +3 more
wiley   +1 more source

The prevalence and years lived with disability of asthma in children under 5 years old in Sichuan Southwest China, 1990–2019: A cross-sectional study

open access: yesFrontiers in Pediatrics, 2022
ObjectivesTo analyze the prevalence and Years Lived with Disability of Asthma in children under 5 years old and the time trends in Sichuan Southwest China from 1990–2019.MethodsBased on the results of the Global Burden of Disease Study 2019 (GBD2019), we
Yu Luo   +5 more
doaj   +1 more source

KIDS COUNT Indicator Brief: Reducing the Teen Death Rate [PDF]

open access: yes, 2009
Reviews data on causes of teen deaths and outlines strategies for improving motor vehicle safety; preventing violence, risky behavior, and suicide; supporting role models; and enhancing families' and communities' capacity to support healthy ...
Barbara Shore, Rima Shore
core  

Outcomes of Live Virus Vaccination in Patients With Vascular Anomalies Being Treated With Sirolimus

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background Live vaccination in patients with vascular anomalies (VA) receiving sirolimus remains controversial due to immunosuppressive effects and theoretical risks. Procedure This single‐center retrospective study included patients with VA less than 4 years old at the start of sirolimus therapy who were incompletely vaccinated.
Svatava Merkle   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy